Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Assessment of the Coagulation Changes Associated With Severe Inflammation in COVID-19 Patients

NCT04460664 is registered in ClinicalTrials.gov with HemoSonics LLC as lead sponsor.

NCT NCT04460664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04460664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Assessment of the Coagulation Changes Associated With Severe Inflammation in COVID-19 Patients
Lead sponsor
HemoSonics LLC
Phase
Observational
Overall status
Completed
Start date
August 14, 2020
Completion date
January 26, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation disorder, covid, disseminated intravascular coagulation